Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
View Patent ↗An assay system designed to detect a protein biomarker in urine that is diagnostic for interstitial cystitis (IC). The presence of a 9 amino acid glycopeptide, antiproliferative factor (APF), in urine is unique to patients with IC. Urine samples from patients who exhibit symptoms consistent with IC are added to the assay system. Binding of APF to the cytoskeletal associated protein 4 (CKAP4) is positive for the presence of APF in urine and diagnostic for IC. The diagnostic system is a significant and surprising advance in diagnosis of IC and has commercial applications relevant to women and men who suffer from symptoms consistent with IC.
1. A method of screening for interstitial cystitis in a patient, said method comprising the steps of:
(a) obtaining a fluid sample from a patient;
(b) applying the sample to a detector device, wherein the detector device is a dipstick device,
wherein the detector device comprises at least one detection reagent,
wherein the detection reagent is a fragment of CKAP4 which comprises a polyhistidine tag at the end of said fragment of CKAP4, and wherein the detection reagent specifically binds antiproliferative factor (APF), further wherein the detection reagent is detectably labeled,
wherein the binding of APF to the detection reagent provides detection of a threshold level of APF in the sample in the form of a visual indication that provides correlation with the presence of interstitial cystitis, and
wherein the threshold level is above about 10 fMolar; and,
(c) visualizing the dipstick device to ascertain a positive screen for interstitial cystitis.
2. The method of claim 1 , wherein the fluid sample is urine.
3. The method of claim 1 , wherein the detection reagent is produced in a bacterial expression system.
4. The method of claim 1 , wherein the detector device visual display comprises a “Yes/No” indicator.